Bupivacaine Hydrochloride, E · 3,125 days since initial FDA posting
Brand: MARCAINE WITH EPINEPHRINE
FDA lists Bupivacaine Hydrochloride, E as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)
- Package NDC
- 0409-1749-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 20, 2018
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Bupivacaine Shortage Records
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC
Injection